GCP
AMED

GSA Capital Partners’s Amedisys AMED Stock Holding History

GSA Capital Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,836
Closed -$1.46M – 1626
2025
Q2 		$1.46M Buy
14,836
+11,484
+343% +$1.09M 0.1% 247
2025
Q1 		$310K Buy
+3,352
New +$309K 0.03% 1123
2024
Q3 		– Sell
-14,100
Closed -$1.29M – 1569
2024
Q2 		$1.29M Buy
+14,100
New +$1.31M 0.09% 346
2024
Q1 		– Sell
-2,214
Closed -$210K – 1577
2023
Q4 		$210K Buy
+2,214
New +$207K 0.02% 1299
2023
Q2 		– Sell
-4,542
Closed -$334K – 1486
2023
Q1 		$334K Sell
4,542
-5,261
-54% -$455K 0.03% 960
2022
Q4 		$819K Buy
+9,803
New +$884K 0.1% 309
2021
Q1 		– Sell
-690
Closed -$202K – 1075
2020
Q4 		$202K Sell
690
-814
-54% -$209K 0.03% 981
2020
Q3 		$356K Buy
+1,504
New +$342K 0.06% 620
2020
Q1 		– Sell
-1,216
Closed -$203K – 1033
2019
Q4 		$203K Sell
1,216
-5,792
-83% -$861K 0.02% 1248
2019
Q3 		$918K Sell
7,008
-4,948
-41% -$644K 0.12% 200
2019
Q2 		$1.45M Sell
11,956
-1,240
-9% -$147K 0.16% 99
2019
Q1 		$1.63M Sell
13,196
-106
-0.8% -$13.3K 0.16% 104
2018
Q4 		$1.56M Sell
13,302
-17,822
-57% -$2.1M 0.18% 91
2018
Q3 		$3.89M Buy
31,124
+11,231
+56% +$1.24M 0.21% 39
2018
Q2 		$1.7M Sell
19,893
-3,756
-16% -$276K 0.08% 363
2018
Q1 		$1.43M Sell
23,649
-220
-0.9% -$12.5K 0.08% 449
2017
Q4 		$1.26M Buy
23,869
+8,849
+59% +$466K 0.08% 458
2017
Q3 		$841K Sell
15,020
-24,028
-62% -$1.27M 0.06% 628
2017
Q2 		$2.45M Sell
39,048
-30,178
-44% -$1.76M 0.16% 99
2017
Q1 		$3.54M Buy
69,226
+4,006
+6% +$191K 0.19% 67
2016
Q4 		$2.78M Buy
65,220
+22,043
+51% +$937K 0.17% 107
2016
Q3 		$2.05M Sell
43,177
-43,500
-50% -$2.17M 0.11% 237
2016
Q2 		$4.38M Buy
86,677
+48,800
+129% +$2.46M 0.24% 29
2016
Q1 		$1.83M Sell
37,877
-315
-0.8% -$12.2K 0.12% 214
2015
Q4 		$1.5M Buy
38,192
+6,437
+20% +$257K 0.07% 417
2015
Q3 		$1.21M Buy
31,755
+2,878
+10% +$121K 0.06% 526
2015
Q2 		$1.15M Sell
28,877
-21,841
-43% -$681K 0.04% 771
2015
Q1 		$1.36M Buy
50,718
+23,400
+86% +$660K 0.05% 635
2014
Q4 		$802K Sell
27,318
-10,040
-27% -$248K 0.06% 613
2014
Q3 		$754K Sell
37,358
-25,014
-40% -$483K 0.04% 673
2014
Q2 		$1.04M Buy
62,372
+17,914
+40% +$254K 0.05% 649
2014
Q1 		$662K Sell
44,458
-28,400
-39% -$437K 0.05% 591
2013
Q4 		$1.07M Buy
72,858
+26,381
+57% +$425K 0.08% 321
2013
Q3 		$800K Buy
46,477
+18,719
+67% +$278K 0.06% 480
2013
Q2 		$322K Buy
+27,758
New +$318K 0.04% 835

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GSA Capital Partners's AMED Position: Q3 2025 in Review

GSA Capital Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14,836 shares — an estimated $1.46M sold.

GSA Capital Partners first reported a position in AMED in Q2 2013 and held it in 35 quarters. The position peaked at $4.38M in Q2 2016. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • GSA Capital Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • GSA Capital Partners sold 14,836 Amedisys shares in Q3 2025, an estimated $1.46M.
  • GSA Capital Partners first reported a position in Amedisys in Q2 2013 and held it in 35 quarters.
  • GSA Capital Partners's Amedisys position peaked at $4.38M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.